Practical Cardiovascular Medicine. Elias B. Hanna

Чтение книги онлайн.

Читать онлайн книгу Practical Cardiovascular Medicine - Elias B. Hanna страница 81

Practical Cardiovascular Medicine - Elias B. Hanna

Скачать книгу

of left ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med 1981; 305: 297–302.

      4 170. Vaitkus PT, Barnathan ES. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta- analysis. J Am Coll Cardiol 1993; 22: 1004–9.

      5 171. Meltzer RS, Visser CA, Fuster V. Intracardiac thrombi and systemic embolization. Ann Intern Med 1986; 104: 689–98. +These 2 old studies: (a) Lapeyre AC 3rd, Steele PM, Kazmier FJ, et al. Systemic embolism in chronic left ventricular aneurysm: incidence and the role of anticoagulation. J Am Coll Cardiol 1985; 6(3):534-8. (b) Reeder GS, Lengyel M, Tajik AJ, Seward JB, Smith HC, Danielson GK. Mural thrombus in left ventricular aneurysm: incidence, role of angiography, and relation between anticoagulation and embolization. Mayo Clin Proc. 1981; 56(2):77–81.

      6 172. Mollet NR, Dymarkowski S, Volders W, et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 2002; 106: 2873–6.

      7 173. Lattuca B, Bouziri N, Kerneis M, et al. Antithrombotic Therapy for Patients With Left Ventricular Mural Thrombus. J Am Coll Cardiol. 2020; 75(14):1676-1685.

      8 174. Robinson AA, Trankle CR, Eubanks G, et al. Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi. JAMA Cardiol. 2020;5(6):685-692. For LV thrombus, NOACs are associated with 2.6 times higher thromboembolic risk compared to warfarin.

      1 175. Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 1999; 281: 707–13.

      1 176. Kern KB. Optimal treatment of patients surviving out-of-hospital cardiac arrest. JACC Cardiovasc Interv 2012; 5: 597–605.

      2 177. Loffi A, Klein LW, Hira RS, et al. SCAI expert consensus statement on out of hospital cardiac arrest. Catheter Cardiovasc Interv 2020, epub doi.org/10.1002/ccd.28990.

      3 178. Lemkes JS, Janssens JN, van der Hoeven NW, et al. Coronary angiography after cardiac arrest without ST-segment elevation. N Engl J Med 2019;380:1397-1407. COACT trial

      4 179. Desch S, Freund A, Akin I, et al. Angiography after out-of-hospital cardiac arrest without ST-segment elevation. N Engl J Med August 2021. DOI: 10.1056/NEJMoa2101909.

      5 180. Dumas F, Cariou A, Manzo-Silberman S. Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry. Circ Cardiovasc Interv 2010; 3: 200–207.

      6 181. Gorjup V, Radsel P, Kocjancic ST, et al. Acute ST-elevation myocardial infarction after successful cardiopulmonary resuscitation. Resuscitation 2007; 72: 379–85.

      7 182. Hosmane VR, Mustafa NG, Reddy VK. Survival and neurologic recovery in patients with ST-segment elevation myocardial infarction resuscitated from cardiac arrest. J Am Coll Cardiol 2009; 53: 409–15.

      8 183. Bougouin W, Dumas F, Karam N, et al. Should we perform an immediate coronary angiogram in all patients after cardiac arrest? Insights from a large French registry. J Am Coll Cardiol 2018; 11(3): 249–256.

      9 184. Larsen AI, Hjørnevik AS, Ellingsen CL, Nilsen DW. Cardiac arrest with continuous mechanical chest compression during percutaneous coronary intervention. A report on the use of the LUCAS device. Resuscitation 2007; 75: 454–9.

      10 185. Bottiger BW, Arntz H, Chamberlain DA, et al. Thrombolysis during resuscitation for out-of-hospital cardiac arrest. N Engl J Med 2008; 359: 2651–62.

      11 186. Arntz HR, Wenzel V, Dissmann R, et al. Out-of-hospital thrombolysis during cardiopulmonary resuscitation in patients with high likelihood of ST-elevation myocardial infarction. Resuscitation 2008; 76: 180–4.

      12 187. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346: 557–63.

      13 188. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346: 549–56.

      14 189. Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33 °C versus 36 °C after cardiac arrest. N Engl J Med 2013; 369: 2197–206.

      15 190. Oomen SS, Menon V. Hypothermia after cardiac arrest: beneficial, but slow to be adopted. Clev Clin J Med 2011; 78: 441–8.

      16 191. Welsford M, Nikolaou NI, Beygui F, et al. Part 5: Acute Coronary Syndromes: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2015; 132(16 Suppl 1):S146–S176.

      17 192. Kilgannon JH, Robert BW, Jones AE, et al. Arterial blood pressure and neurologic outcome after resuscitation from cardiac arrest. Crit Care Med 2014; 42: 2083–91.

      1 * ACC defines DTB as the time from first medical contact (FMC) to first establishment of reperfusion with an interventional device; the preferred term is “FMC-to-device time.” FMC is the time of on-scene arrival of emergency medical service, or the time of hospital arrival in case the patient transports himself. First establishment of reperfusion corresponds to the first balloon inflation or thrombectomy that successfully re-establishes coronary flow. Note that the term DTB is not used in ESC guidelines: “STEMI diagnosis-to-wire crossing” is used instead.

        I. Causes of angina and pathophysiology of coronary flow

        II. Diagnostic approach

        III. Silent myocardial ischemia. Is there a role for screening asymptomatic patients and post-PCI patients?

        IV. Medical therapy: antiplatelet therapy

        V. Medical therapy: antianginal therapy and risk factor control

        VI. Indications for revascularization

        VII. CABG and CABG vs. medical therapy

        VIII. PCI and PCI vs medical therapy

       

Скачать книгу